CLDX
Celldex Therapeutics Inc.

9,695
Mkt Cap
$1.61B
Volume
273.00
52W High
$30.50
52W Low
$14.40
PE Ratio
-7.18
CLDX Fundamentals
Price
$22.58
Prev Close
$24.27
Open
$24.04
50D MA
$26.53
Beta
1.07
Avg. Volume
661,305.70
EPS (Annual)
-$2.45
P/B
2.70
Rev/Employee
$37,741.93
Loading...
Loading...
News
all
press releases
Celldex Therapeutics Breaks Below 200-Day Moving Average - Notable for CLDX
In trading on Thursday, shares of Celldex Therapeutics, Inc. (Symbol: CLDX) crossed below their 200 day moving average of $23.76, changing hands as low as $23.61 per share. Celldex Therapeutics, Inc...
Nasdaq News: Markets·19h ago
News Placeholder
More News
News Placeholder
Celldex Therapeutics, Inc. (NASDAQ:CLDX) Given Average Recommendation of "Moderate Buy" by Brokerages
Shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the ten brokerages that are covering the company, MarketBeat.com...
MarketBeat·5d ago
News Placeholder
Celldex Therapeutics, Inc. (NASDAQ:CLDX) Sees Large Growth in Short Interest
Celldex Therapeutics, Inc. (NASDAQ:CLDX - Get Free Report) was the target of a large increase in short interest in the month of December. As of December 31st, there was short interest totaling...
MarketBeat·18d ago
News Placeholder
Celldex Therapeutics (NASDAQ:CLDX) Trading Down 7.5% - Here's Why
Celldex Therapeutics (NASDAQ:CLDX) Stock Price Down 7.5% - Should You Sell...
MarketBeat·24d ago
News Placeholder
Celldex Therapeutics SVPs Engage In Heavy Transactions
Key PointsFreddy A. Jimenez directly sold 4,166 shares for a transaction value of $121,210 on Dec. 4, 2025...
Nasdaq News: Markets·25d ago
News Placeholder
Celldex Therapeutics, Inc. (NASDAQ:CLDX) Given Consensus Rating of "Moderate Buy" by Analysts
Celldex Therapeutics, Inc. (NASDAQ:CLDX - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the eleven research firms that are covering the stock, Marketbeat...
MarketBeat·1mo ago
News Placeholder
Celldex Therapeutics (NASDAQ:CLDX) Trading 4.1% Higher - Should You Buy?
Celldex Therapeutics (NASDAQ:CLDX) Shares Up 4.1% - Here's Why...
MarketBeat·1mo ago
News Placeholder
Simplify Asset Management Inc. Invests $2.20 Million in Celldex Therapeutics, Inc. $CLDX
Simplify Asset Management Inc. purchased a new position in shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX - Free Report) during the third quarter, according to its most recent Form 13F filing with...
MarketBeat·1mo ago
News Placeholder
Short Interest in Celldex Therapeutics, Inc. (NASDAQ:CLDX) Declines By 20.9%
Celldex Therapeutics, Inc. (NASDAQ:CLDX - Get Free Report) was the recipient of a large decrease in short interest during the month of December. As of December 15th, there was short interest totaling...
MarketBeat·1mo ago
News Placeholder
Celldex Therapeutics (NASDAQ:CLDX) Stock Price Crosses Above Two Hundred Day Moving Average - Here's What Happened
Celldex Therapeutics (NASDAQ:CLDX) Stock Price Crosses Above 200 Day Moving Average - Time to Sell...
MarketBeat·1mo ago
<
1
2
...
>

Latest CLDX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.